Irackly Mtibelishvily
Nessuna posizione attualmente
Storia della carriera di Irackly Mtibelishvily
Precedenti posizioni note di Irackly Mtibelishvily
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARGOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/12/2016 | 30/11/2018 |
Formazione di Irackly Mtibelishvily
| University of Virginia School of Law | Graduate Degree |
| Moscow State Institute of International Relations | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Russia | 2 |
Posizioni
| Graduate Degree | 2 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
